Cargando…
Effect of various Danshen injections on patients with coronary heart disease after percutaneous coronary intervention: A protocol for a systematic review and network meta-analysis
BACKGROUND: Patients with coronary heart disease (CHD) who undergo percutaneous coronary intervention (PCI) have a certain risk of vascular complications, including coronary restenosis and thrombosis. Many recent randomized controlled trials have reported that Danshen injection (DSI) combined with c...
Autores principales: | Zhu, Zehao, Wang, Yuanping, Liao, Weilin, Li, Huimin, Wang, Dawei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023694/ https://www.ncbi.nlm.nih.gov/pubmed/29901609 http://dx.doi.org/10.1097/MD.0000000000011062 |
Ejemplares similares
-
The Efficacy and Safety of Compound Danshen Dripping Pill Combined with Percutaneous Coronary Intervention for Coronary Heart Disease
por: Li, Cailan, et al.
Publicado: (2020) -
Effects of compound Danshen dropping pills on adverse cardiovascular events and quality of life after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis
por: Lv, Lina, et al.
Publicado: (2022) -
Compound Danshen Dripping Pill Pretreatment to Prevent Contrast-Induced Nephropathy in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Yang, Rong, et al.
Publicado: (2014) -
A Review of Danshen Combined with Clopidogrel in the Treatment of Coronary Heart Disease
por: Zhang, Zhaojian, et al.
Publicado: (2019) -
Compound Danshen dripping pills in treating with coronary heart disease: A protocol for systematic review and meta-analysis
por: Sun, Ling, et al.
Publicado: (2022)